LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on MoonLake Immunotherapeutics today and set a price target of $16.00. The company...
LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on MoonLake Immunotherapeutics today and set a price target of $16.00. The company...